Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
iSpecimen ( (ISPC) ) has provided an update.
On December 30, 2025, iSpecimen Inc. entered into a Securities Purchase Agreement with accredited investors to issue 6,875 shares of newly created Series C Convertible Non-Voting Preferred Stock, each with a stated value of $1,000 and sold at $800 per share, and on December 31, 2025 closed the transaction for aggregate gross proceeds of $5.5 million. The Series C preferred shares, which were structured to rank senior to common stock in dividends and liquidation and carry no general voting rights, are convertible into common shares at 85% of the prior trading day’s closing price, subject to a floor price, and were sold in a private placement under Regulation D, with iSpecimen granting investors registration rights for the resale of conversion shares and appointing E.F. Hutton & Co. as exclusive placement agent, a move that strengthens the company’s capital position but introduces potential future equity dilution for existing shareholders.
The most recent analyst rating on (ISPC) stock is a Sell with a $0.28 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Underperform.
The score is driven primarily by weak financial performance (declining revenue, ongoing losses, and negative cash flow) and very bearish technicals (below major moving averages with negative MACD). Valuation offers limited support due to negative earnings and no dividend, while corporate events are mixed—equity compliance regained but bid-price delisting risk remains.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
iSpecimen Inc. is a Nasdaq-listed Delaware corporation that issues common and preferred equity securities and operates in the broader life sciences and biomedical research ecosystem, using capital markets financing to support its business activities and growth initiatives.
Average Trading Volume: 1,052,088
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.54M
Learn more about ISPC stock on TipRanks’ Stock Analysis page.